by Dylan Berman | Sep 23, 2026 | General
Devon Energy Corporation (NYSE:DVN) is trending Wednesday after CNBC reported that activist hedge fund Toms Capital Management sent a letter urging the company to explore strategic alternatives, including a sale. Devon shares are trending higher. What’s pushing DVN...
by Surbhi Jain | Sep 23, 2026 | General
A sharp rebound in Bitcoin (CRYPTO:$BTC) has lifted the value of Tesla Inc’s (NASDAQ:TSLA) long-held stash, while the mechanics behind the crypto rally are raising a more important question for investors: How much of the move can last? According to Arkham data, Tesla...
by Daragh Thomas | Sep 23, 2026 | General
Artificial intelligence companies may be building far more compute than it ultimately needs, according to Tyler Saltsman, CEO of EdgeRunner AI. The compute being built is “a little overkill,” Saltsman told Benzinga. “I think what will happen is AI will become too...
by Henry Khederian | Sep 23, 2026 | General
Jaguar Health Inc. (NASDAQ:JAGX) shares are plunging Wednesday morning as profit-taking reverses an explosive Tuesday rally sparked by regulatory fee waivers. Jaguar Health stock is taking a hit today. What’s behind JAGX decline? Low-Float Volatility and Profit-Taking...
by Benzinga Insights | Sep 23, 2026 | General
Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 8.16% on an annualized basis producing an average annual return of 21.6%. Currently, Halozyme Therapeutics has a market capitalization of $13.13 billion. Buying $1000 In HALO: If...
Recent Comments